Literature DB >> 16050677

New cytotoxic salinosporamides from the marine Actinomycete Salinispora tropica.

Philip G Williams1, Greg O Buchanan, Robert H Feling, Christopher A Kauffman, Paul R Jensen, William Fenical.   

Abstract

An extensive study of the secondary metabolites produced by the obligate marine actinomycete Salinispora tropica (strain CNB-392), the producing microbe of the potent proteasome inhibitor salinosporamide A (1), has led to the isolation of seven related gamma-lactams. The most important of these compounds were salinosporamide B (3), which is the deschloro-analogue of 1, and salinosporamide C (4), which is a decarboxylated pyrrole analogue. New SAR data for all eight compounds, derived from extensive testing against the human colon carcinoma HCT-116 and the 60-cell-line panel at the NCI, indicate that the chloroethyl moiety plays a major role in the enhanced activity of 1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16050677     DOI: 10.1021/jo050511+

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  45 in total

Review 1.  Salinosporamide natural products: Potent 20 S proteasome inhibitors as promising cancer chemotherapeutics.

Authors:  Tobias A M Gulder; Bradley S Moore
Journal:  Angew Chem Int Ed Engl       Date:  2010-12-03       Impact factor: 15.336

Review 2.  Taxonomy, Physiology, and Natural Products of Actinobacteria.

Authors:  Essaid Ait Barka; Parul Vatsa; Lisa Sanchez; Nathalie Gaveau-Vaillant; Cedric Jacquard; Jan P Meier-Kolthoff; Hans-Peter Klenk; Christophe Clément; Yder Ouhdouch; Gilles P van Wezel
Journal:  Microbiol Mol Biol Rev       Date:  2015-11-25       Impact factor: 11.056

Review 3.  Halogenase engineering and its utility in medicinal chemistry.

Authors:  Amy E Fraley; David H Sherman
Journal:  Bioorg Med Chem Lett       Date:  2018-04-30       Impact factor: 2.823

4.  New drugs from marine microbes: the tide is turning.

Authors:  David J Newman; Russell T Hill
Journal:  J Ind Microbiol Biotechnol       Date:  2006-04-06       Impact factor: 3.346

5.  Proteasome regulator marizomib (NPI-0052) exhibits prolonged inhibition, attenuated efflux, and greater cytotoxicity than its reversible analogs.

Authors:  Amanda Obaidat; Jeffrey Weiss; Brett Wahlgren; Rama R Manam; Venkat R Macherla; Katherine McArthur; Ta-Hsiang Chao; Michael A Palladino; G Kenneth Lloyd; Barbara C Potts; Salvatore J Enna; Saskia T C Neuteboom; Bruno Hagenbuch
Journal:  J Pharmacol Exp Ther       Date:  2011-02-08       Impact factor: 4.030

6.  Concise total synthesis of (+/-)-salinosporamide A, (+/-)-cinnabaramide A, and derivatives via a bis-cyclization process: implications for a biosynthetic pathway?

Authors:  Gil Ma; Henry Nguyen; Daniel Romo
Journal:  Org Lett       Date:  2007-05-04       Impact factor: 6.005

7.  Engineering fluorometabolite production: fluorinase expression in Salinispora tropica Yields Fluorosalinosporamide.

Authors:  Alessandra S Eustáquio; David O'Hagan; Bradley S Moore
Journal:  J Nat Prod       Date:  2010-03-26       Impact factor: 4.050

8.  Biosynthesis of salinosporamides from alpha,beta-unsaturated fatty acids: implications for extending polyketide synthase diversity.

Authors:  Yuan Liu; Christopher Hazzard; Alessandra S Eustáquio; Kevin A Reynolds; Bradley S Moore
Journal:  J Am Chem Soc       Date:  2009-08-05       Impact factor: 15.419

Review 9.  Antitumor compounds from marine actinomycetes.

Authors:  Carlos Olano; Carmen Méndez; José A Salas
Journal:  Mar Drugs       Date:  2009-06-11       Impact factor: 5.118

Review 10.  Development of novel drugs from marine surface associated microorganisms.

Authors:  Anahit Penesyan; Staffan Kjelleberg; Suhelen Egan
Journal:  Mar Drugs       Date:  2010-03-01       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.